Valion Bio (VBIO) Return on Capital Employed [ROCE] (2022 - 2026)
Valion Bio (VBIO) posted Return on Capital Employed [ROCE] of -43.32% for Q2 2026, up 104.60 percentage points from -147.92% a year earlier.
Powered by 
Analysis
Valion Bio (VBIO) Return on Capital Employed [ROCE] (2022 - 2026) Analysis & Trends
For FY2025, Valion Bio's Return on Capital Employed [ROCE] came in at -47.69%, up 72.96 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] shows a three-year change of +70.04 percentage points (FY2022 to FY2025).
- In prior years, Valion Bio's Return on Capital Employed [ROCE] was -120.65% in FY2024 (+79.72 pp), -200.36% in FY2023 (-82.64 pp) and -117.73% in FY2022.
- Quarterly Return on Capital Employed [ROCE] has run from a low of -235.64% in Q1 2024 to a high of -41.82% in Q4 2025 over five years.
- On a year-over-year basis, Return on Capital Employed [ROCE] increased in six of the last seven quarters, with an average year-over-year change of +56.02 percentage points.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2025, with a gain of 116.42 percentage points; the weakest was Q1 2023, with a drop of 149.54 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 11.32% |
| 10 | Valion Bio | 73,008.00 | -25.39 Mn | - | -51.14% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -51.14% |
| Mar 31, 2026 | -36.44% |
| Dec 31, 2025 | -41.12% |
| Sep 30, 2025 | -123.37% |
| Jun 30, 2025 | -144.03% |
| Mar 31, 2025 | -171.38% |
| Dec 31, 2024 | -158.25% |
| Sep 30, 2024 | -182.00% |
| Jun 30, 2024 | -196.05% |
| Mar 31, 2024 | -235.64% |
| Dec 31, 2023 | -176.14% |
| Sep 30, 2023 | -171.97% |
| Jun 30, 2023 | -193.69% |
| Mar 31, 2023 | -202.93% |
| Dec 31, 2022 | -195.58% |
| Sep 30, 2022 | -133.46% |
| Jun 30, 2022 | -92.60% |
| Mar 31, 2022 | -53.39% |
API Access
Valion Bio Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();